Previous Article | Next Article 
Volume 17, Number 4,
Issue of February 15, 1997
pp. 1217-1225
Copyright ©1997 Society for Neuroscience
Characterization of a CNS Cell Line, CAD, in which Morphological
Differentiation Is Initiated by Serum Deprivation
Yanping Qi2,
James K. T. Wang2,
Michael McMillian1, and
Dona M. Chikaraishi1
1 Department of Neurobiology, Duke University Medical
Center, Durham, North Carolina 27710, and 2 Department of
Neuroscience, Tufts University School of Medicine, Boston,
Massachusetts 02111
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
A CNS catecholaminergic cell line, Cath.a, was established by
targeted oncogenesis in transgenic mice. Cath.a cells express neuronal
properties but lack neuronal morphology. Here, we describe a variant of
Cath.a, called CAD (Cath.a-differentiated), in which reversible
morphological differentiation can be initiated by removal of serum or
exogenously added protein from the medium. In serum- or protein-free
media, CAD cells stop proliferating and extend long processes.
Differentiated CAD cells can be maintained without serum or protein for
at least 6 weeks. CAD cells are distinct from Cath.a cells; most
significant, the original immortalizing oncogene, SV40 T antigen, was
spontaneously lost. By immunostaining or immunoblotting, we show that
CAD cells express neuron-specific proteins, such as class III
-tubulin, GAP-43, SNAP-25, and synaptotagmin, but not GFAP.
Ultrastructurally, processes from differentiated CAD cells have
abundant parallel microtubules and intermediate filaments, and bear
varicosities that contain both large dense-core vesicles/granules
(120-160 nm) and smaller clear vesicles (60-80 nm). Additionally, CAD
cells express enzymatically active tyrosine hydroxylase and accumulate
L-DOPA. CAD cells exhibit biochemical and morphological
characteristics of primary neurons and provide an unique tool for
studying neuronal differentiation.
Key words:
CNS cell line;
catecholamine;
tyrosine hydroxylase;
neuronal differentiation;
T antigen;
microtubule;
intermediate
filament;
synaptic vesicle
INTRODUCTION
Regulation of neurogenesis within the CNS is a
central focus in developmental neurobiology. Identifying factors that
induce differentiation of neuronal precursors has been particularly
difficult to carry out in vivo. Because of the cellular
complexity of the brain, with cells of different types intermingled and
differentiating at different times, molecular analyses have been
limited mainly to cultured primary neurons or cell lines. Whereas
primary cultures from different brain regions have been studied
successfully, pure neuronal cultures are often difficult to prepare. In
primary cultures, the presence of glia, which are a rich source of
growth and trophic factors, complicates the search for molecules that
mediate neuronal maturation. In addition, the number of primary neurons
that can be obtained may be limited for studies on discrete neuronal
populations. On the other hand, immortalized cell lines obviate many of
these difficulties, but their differentiation is usually limited. In addition, they often express high levels of an immortalizing oncogene and are rarely of purely CNS origin.
Among the immortalized cell lines that have been studied, several can
be induced to differentiate by altering growth conditions or by adding
trophic factors. The neuroblastoma C-1300 cell line, derived from a
spontaneous murine tumor, differentiates in low serum into neurons that
are excitable, bear long processes, and express
neurotransmitter-synthesizing enzymes (Augusti-Tocco and Sato, 1969
;
Nelson et al., 1969
; Schubert et al., 1969
; Seeds et al., 1970
; Amano
et al., 1972
). P19 cells, an embryonal carcinoma cell line, can be
induced to differentiate morphologically and biochemically with
retinoic acid (Jones-Villeneuve et al., 1982
). P19 cells form
structures resembling chemical synapses (McBurney et al., 1988
; Yao et
al., 1995
) and extend processes that are polarized into dendrites and
axons. However, retinoic acid-treated P19 cells also give rise to glia
and fibroblast-like cells. Similar to P19, a human teratocarcinoma cell
line, NTere 2/cl.D1 (NT2) differentiates into postmitotic neurons
(NT2-N) in response to retinoic acid (Pleasure and Lee, 1993
; Younkin
et al., 1993
). NT2 cells elaborate processes that can be identified as
dendrites and axons, and express a number of neuron-specific proteins
including glutamate receptor channels (Pleasure et al., 1992
; Younkin
et al., 1993
). PC12 cells are a neuroendocrine cell line derived from a
rat pheochromocytoma (Greene and Tischler, 1976
). Like neonatal
chromaffin cells, PC12 cells differentiate into sympathetic neurons
after nerve growth factor treatment and exhibit many neuronal properties (Tao-Cheng et al., 1995
).
A CNS catecholaminergic cell line, Cath.a, was established from a brain
tumor that arose in a transgenic mouse carrying wild-type SV40 T
antigen (Tag) under the transcriptional control of the rat tyrosine
hydroxylase promoter (Suri et al., 1993
). In addition to making
dopamine and norepinephrine, Cath.a cells express a variety of
pan-neuronal markers, including neurofilaments, synaptophysin, and
voltage-gated Na+, K+, and Ca2+ channels (Suri
et al., 1993
; Lazaroff et al., 1996
). However, these cells do not bear
neurites, nor can be they induced to morphologically differentiate
under any conditions tested thus far.
We report here the characterization of a variant of Cath.a, called CAD,
in which neuronal differentiation can be initiated by serum
deprivation. The cells can be maintained in a differentiated state
without any protein added to the culture media. CAD cells differ
significantly from the parental Cath.a line; notable is the fact that
they have lost the immortalizing oncogene. These cells express
neuron-specific proteins not expressed in the parental line and
synaptic vesicle proteins, and they bear processes and varicosities
that resemble those of neurons. Like the parental Cath.a cell line, CAD
cells express bioactive tyrosine hydroxylase. The characteristics of
this cell line make it a valuable in vitro system to study
neuronal differentiation.
MATERIALS AND METHODS
Cell culture. Cath.a cells were cultured as described
previously (Suri et al., 1993
). CAD cells were grown in DMEM/F-12
medium (DF12, catalog #12-719F; BioWhittaker, Walkersville, MD),
supplemented with 8% FBS (HyClone, Logan, UT) and 1%
penicillin-streptomycin (100% stocks, 10,000 U/ml penicillin G sodium
and 10,000 µg/ml streptomycin sulfate in 0.85% saline, Gibco,
Gaithersburg, MD) on standard tissue culture dishes in a humidified 5%
C02 incubator. CAD cells were passaged every 3-4 d by
pipetting cells from a confluent plate and triturating them in 5 ml of
fresh medium. Cells were replated at a 1:10 dilution. To induce
differentiation, CAD cells were plated in serum-containing DF12 medium,
and then switched to either serum-free medium (SFM) or protein-free
medium (PFM). SFM contained 20 µg/ml transferrin (Sigma, St. Louis,
MO) and 50 ng/ml sodium selenite (Sigma) in DF12 medium; PFM contained 50 ng/ml sodium selenite only. Differentiated CAD cells were grown for
at least 5 d in SFM or PFM before they were used for
immunostaining or Western blots. Rat HTC cells, C6 glioma cells, and
fibroblast cells were grown in the same medium as the CAD cells.
Southern blot. Genomic DNA was isolated by the method of
Laird et al. (1991)
. Ten micrograms of genomic DNA was digested with BamHI and HindIII and separated by
electrophoresis through a 0.8% agarose gel as described (Maniatis et
al., 1989
). Restricted DNA was transferred to a GeneScreen plus nylon
membrane (Dupont, Boston, MA) and probed with 32P-Tag DNA
labeled by random priming.
Cell count. For the cell counts, cells were plated at 4 × 104 cells/well (Fig. 2A) or 2 × 104 cells/well (Fig. 2B) in a 6-well
tissue culture plate. On day 0, after the cells attached to the plate,
they were washed two times with DF12 medium, and then SFM or PFM was
added to the appropriate wells. At each time point, cells were detached
with trypsin-EDTA and collected by centrifugation. Cell number was
determined with a hemocytometer.
Fig. 2.
Reversible reduction of cell proliferation rate in
SFM or PFM. A, Growth curve of CAD cells. Cells were
grown in serum-containing medium; on day 0 (D0), they
were changed into SFM or PFM or maintained in serum-containing medium
for an additional 4 d. Values are the average of the cell number
from four separate experiments. The cell number was obtained as
described in Materials and Methods. B, Differentiated
CAD cells resumed proliferation after serum addition. CAD cells were
maintained in SFM or PFM for 4 d, after which FBS was added to a
final concentration of 8% to the culture medium.
Arrowhead indicates serum addition. Error bars indicate SEM (n = 4). Note: some of the error bars are too
small to be visible.
[View Larger Version of this Image (15K GIF file)]
Immunostaining. Cells were grown on glass coverslips
precoated with cell-TAK (Becton Dickinson, Bedford, MA). After 4-5 d, the cells were washed once with PBS and fixed with cold methanol for 10 min. Cells were incubated in primary antibodies for 1.5 to 2 hr at room
temperature. Synaptotagmin antibody was applied as undiluted hybridoma
culture supernatant. For TuJ1 and TH staining, the antibodies were
diluted at 1:1000 and 1:500, respectively, in PBS with 10 mg/ml BSA and
0.1% Triton X-100. Cells were washed with PBS and incubated with
secondary antibody (at 1:250 in the same diluent used for the primary
antibodies) conjugated either with fluorescein (Sigma) or biotin
(Vector Laboratories, Burlingame, CA) for 1-2 hr at room temperature.
Biotin-labeled secondary antibody was detected with streptavidin
conjugated with Texas Red (Gibco, Gaithersburg, MD) used at 1:200. For
controls, cells were processed the same way, except that primary
antibodies were omitted from the initial incubation. No significant
staining was observed with any of the secondary antibodies alone (data
not shown).
Western blots. Confluent 100 mm plates of cells were washed
once with sterile PBS and lysed directly on the plate with 1 ml 2%
SDS, 100 µg/ml PMSF, 5 µg/ml aprotinin, and 5 µg/ml leupeptin. Lysates were sonicated for 15 sec to shear chromosomal DNA. Protein concentration was determined with BCA protein assay reagent (Pierce Chemical, Rockford, IL). Fifty micrograms of protein was loaded per
lane onto an 10% acrylamide-SDS gel and transferred
electrophoretically to an immobilon-P membrane (Millipore, Bedford,
MA). After washing with TBS/0.05% Tween 20 (TBST), nonspecific binding
was blocked by incubating the membrane for 30 min in TBST containing
5% Carnation nonfat dry milk. Primary antibodies were diluted in the
same blocking solution at 1:5000 for Tag and SNAP-25 antibodies, 1:1000
for GAP-43 antibody, and 1:500 for GFAP antibody. The membrane was incubated in primary antibodies for 1 to 1.5 hr at room temperature, washed 3 times with TBST, and incubated with secondary antibodies conjugated with horseradish peroxidase at a 1:5000 dilution for 0.5 hr.
The membrane was washed three times with TBST and once with TBS, and
the bands were visualized by the ECL detection system (Amersham,
Arlington Heights, IL).
Antibodies. Antibodies were obtained as follows: TH
monoclonal antibody (mAb) from INCSTAR (Stillwater, MN); GFAP mAb from Biomedical Technologies (Stoughton, MA); GAP-43 mAb from Sigma; monoclonal SNAP-25 from Sternberger Monoclonals (Baltimore, MD). The
rabbit polyclonal Tag antibody was the kind gift of Dr. Doug Hanahan
(University of California at San Francisco), and the mAbs to TuJ1 and
synaptotagmin (clone 48) were generously provided by Dr. Anthony
Frankfurter (University of Virginia) and Dr. William Matthew (Duke
University), respectively.
HPLC. L-DOPA and dopamine were assayed by HPLC
with electrochemical detection. Mobile phase consisted of 10%
methanol, 50 mM NaH2PO4, pH 3.6, 0.387 mM sodium octyl sulfate, and 0.1 mM EDTA.
The reverse-phase column was Ultremex 3 µm, C18
(Phenomenex, Torrence, CA). Plates of cells were scraped, pelleted, and
sonicated in 0.5 ml 0.1 N perchloric acid. Disrupted cells were
centrifuged (14,000× g, 4°C, 10 min), and the pellets
were used for protein determination. Supernatant was filtered through
0.45 µm nylon centrifuge filters (Fisher Scientific, Pittsburgh, PA),
and 20 µl per sample was injected onto the HPLC. The applied
potential of detector was 0.7 V.
Cell pellets were dissolved in 1 N NaOH, and the protein content in
each plate was determined with BCA protein assay reagent (Pierce
Chemical, Rockford, IL).
Electron microscopy. Cells were grown on 60 mm tissue
culture plates. Fixation was carried out at room temperature with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, from 30 min to overnight. Cells were washed twice with buffer,
postfixed with 1% osmium tetroxide, and then mordanted in 1% uranyl
acetate for 30 min. After another wash, cells were dehydrated and
embedded in pure Epon.
RESULTS
Reversible morphological differentiation in CAD cells
In culture, Cath.a cells are small (~15 µm in diameter),
lack processes, and grow in clumps (Fig.
1A). Cells bearing short processes
spontaneously appeared in cultures of Cath.a cells and were selected by
two cycles of single cell cloning. Clonality was assured by visually
selecting single cells in microtiter wells for each cycle of cloning.
The resulting cells, named CAD (for Cath.a-differentiated), appear
bigger and flatter, and grow in a more dispersed manner (Fig.
1B). They also exhibit short processes similar to the
initial uncloned population. When CAD cells are switched to SFM or PFM,
they undergo a dramatic morphological change. Within 1 day, the cells
start to put out processes. Four days after culturing in SFM or PFM,
most cells have long processes with varicosities (Fig.
1C,D). Under these conditions, differentiated CAD cells
appear healthy despite the lack of exogenously added protein in the
media. They can be maintained in this state for a minimum of 6 weeks,
after which time they tend to lift off the plates as monolayers after
mechanical disturbance. Detachment is probably a result of lack of
appropriate substratum rather than death of the cells because the
detached sheets can be triturated and the cells replated without serum.
Coating of tissue culture dish with polylysine, collagen, laminin, or
cell Tak did not prevent the tendency of the differentiated cells to
lift off, although laminin did promote the initial outgrowth of
processes (data not shown). In contrast, when the parental Cath.a cells
were switched to SFM, they died.
Fig. 1.
Morphological differentiation can be induced in
CAD cells. Phase-contrast photomicrograph of live cells: Cath.a cells
in serum-containing medium (A); CAD cells in
serum-containing medium (B), SFM (C), or
PFM (D). In C and D, the
cells were grown for 5 d in SFM or PFM. Note the beaded
varicosities on the processes. Scale bar, 100 µm.
[View Larger Version of this Image (100K GIF file)]
Because many cells stop dividing when they differentiate, the growth
rate of CAD cells was assessed after differentiation. As shown in
Figure 2A, in serum, the cell number
doubles every 18-22 hr. Three days after plating, cell proliferation
slows as the cells reached confluence. In SFM, the proliferation rate
decreases three- to fourfold, and in PFM, no significant increase in
cell number occurred over 4 d.
To determine whether CAD cell differentiation is reversible,
serum was added back after the cells were maintained in SFM or PFM for
4 d. By time lapse videomicroscopy, we observed that more than
95% of the differentiated cells retracted their processes within
12-24 hr (data not shown). The cell count (Fig. 2B)
shows that the cell number increased after serum addition, doubling every 18-22 hr. The fact that the rate of growth was the same as that
of serum-grown cultures (Fig. 2A) suggests that the
cells fully recover the ability to cycle. Moreover, the fact that the first doubling occurs within the first 18-22 hr suggests that virtually all of the cells reenter the cycle without a lag period. Therefore, morphological differentiation concomitant with growth arrest
can be initiated in CAD cells by serum or protein deprivation, and this
event is readily reversible.
SV40 T antigen oncogene is lost in CAD cells
Parental Cath.a cells were immortalized by SV40 T antigen (Tag),
which stimulates cell proliferation mainly by binding p53 and
retinoblastoma proteins (Fanning, 1992
; Bryan and Reddel, 1994
). Cath.a
cells express high levels of Tag, which is likely to keep the cells in
the cycle and block morphological differentiation. To determine whether
the CAD cells also express Tag, Western blots were performed. As shown
in Figure 3A, robust Tag expression was found
in Cath.a cells, but, to our surprise, no detectable Tag protein was
observed in CAD cells.
Fig. 3.
SV40 T antigen (Tag) is lost in CAD cells.
A, Western blot analysis with Tag-specific polyclonal
antibody. Each lane contains 50 µg of protein. Tag was detected in
Cath.a cells (CA) as a doublet. No Tag was detected in
CAD cells. B, Southern blot analysis with a
32P-labeled Tag probe. Tag is only detected in Cath.a
cells, but not in CAD or PC12 cells. PC, PC12 cells;
KD, kilodalton.
[View Larger Version of this Image (49K GIF file)]
The presence of the Tag gene in the CAD genome was then tested by
Southern blots. The original construct used to create the TH-Tag
transgenic mice contains a unique BamHI restriction site and
three HindIII restriction sites, such that BamHI
digestion would be expected to give a fragment bigger than 3.2 kb and
HindIII, a 1.7 kb fragment (see Suri et al., 1993
for the
plasmid construct). As expected, in Cath.a cells, 4.4 kb and 1.7 kb
Tag-containing fragments were observed with BamHI and
HindIII digests, respectively (Fig. 3B). In CAD
cells, no Tag-containing fragments were detected, suggesting that the
Tag gene was lost in CAD cells. This result was also confirmed by PCR
with genomic DNA (data not shown).
CAD cells express neuron-specific proteins
The phenotype of CAD cells was evaluated with several neuronal
markers including neuronal-specific class III
-tubulin, GAP-43, and
SNAP-25. Class III
-tubulin is a tubulin isotype expressed specifically in neurons (Sullivan et al., 1986
) and is recognized by a
mAb, TuJ1, specific for an epitope unique to the class III
-tubulin
isotype. TuJ1 has been shown to label neurons specifically. By
immunocytochemistry, intense cytoplasmic staining was observed in
Cath.a cells, CAD cells, and differentiated CAD cells (Fig. 4A-C). Note that all of the processes
in differentiated CAD cells were stained evenly with the TuJ1
antibody.
Fig. 4.
CAD cells express neuron-specific proteins.
A-C, Immunocytochemical staining with TuJ1 mAb against
class III
-tubulin. Cath.a (A), undifferentiated CAD
(B), and differentiated CAD (C) cells were all stained with TuJ1 antibody. D-F,
Western blot with antibodies against GAP-43 (D),
SNAP-25 (E), and GFAP (F). Fifty
micrograms of Cath.a (CA), CAD, and differentiated CAD
(CADd) cell protein were loaded in each lane.
GAP-43 was detected in both CAD cells and rat brain synaptosome
(SYN) extracts. GAP-43 protein was
increased twofold after differentiation (CADd). However,
no GAP-43 was detected in Cath.a cells. SNAP-25 was detected in
both CAD cells and synaptosome extracts, but not in Cath.a cells
(E). In F, Cath.a, CAD, and fibroblasts
(FB) did not express the glial-specific protein GFAP, although extracts from mouse cerebellum (Cere.) had
abundant GFAP.
[View Larger Version of this Image (76K GIF file)]
GAP-43 and SNAP-25 are thought to be essential in synapse
formation and in maturation of synaptic contacts (Catsicas et al., 1991
, 1993; Osen-Sand et al., 1993; Lakin et al., 1995
; Sabel et al.,
1995
). They are expressed by virtually all maturing neurons. GAP-43 is
a membrane-bound protein found at high levels in the axons and growth
cones of developing and regenerating neurons (Kalil and Skene, 1986
;
Skene et al., 1986
; Strittmatter et al., 1992
). SNAP-25 is a
presynaptic protein that is closely associated with integral membrane
proteins in presynaptic membranes, and has been found to be essential
in vesicle docking and fusion (Oyler et al., 1991
, 1992; Pevsner et
al., 1994
). To determine whether GAP-43 and SNAP-25 are expressed in
CAD cells and whether they are increased after differentiation, Western
blots were performed. GAP-43 was observed in serum-grown CAD cells and
was increased approximately twofold after differentiation (Fig.
4D). Its concentration in differentiated CAD cells
was approximately one-half that observed in rat brain synaptosomes. In
contrast, GAP-43 was not detected in the parental Cath.a cells (Fig.
4D) or in C6 glioma cells (data not shown). SNAP-25
was also detected in CAD, but its level was not increased after
differentiation (Fig. 4E). Little or no SNAP-25 was
detected in Cath.a cells, suggesting that both SNAP-25 and GAP-43
proteins are increased in CAD compared with parental Cath.a cells,
consistent with the neuronal morphology exhibited by CAD cells.
Because many immortalized cells exhibit a neuroglial phenotype
(Schubert et al., 1974
) and express both neuronal and glial proteins,
we determined whether glial fibrillary acidic protein (GFAP) was
expressed in CAD cells. GFAP is a 51 kDa intermediate filament protein
that is expressed specifically in astrocytes (Eng, 1985
). As shown in
Figure 4F, GFAP was detected in mouse cerebellum, a
rich source of GFAP, but not in Cath.a and CAD cells, nor in fibroblast
cells.
In summary, CAD cells express neuron-specific proteins, but not a glial
marker, which supports the morphological data suggesting they are
neuronal in nature.
Ultrastructurally, differentiated CAD cells resemble a
primary neuron
The morphological differentiation and presynaptic protein
expression in CAD cells prompted us to investigate whether CAD cells have cytoskeletal and vesicular structures typical of neurons. Under
electron microscopy, cellular organelles including mitochondria, endoplasmic reticulum, and abundant polyribosomes were easily identified in the cell body of differentiated CAD cells (Fig. 5A). Randomly oriented microtubules could be
detected in the cytoplasm. Where a process initiated, microtubules and
intermediate filaments assumed an orientation parallel to the process.
Except for mitochondria, organelles found in the cell body were largely
excluded from the process. Figure 5B showed a typical
process filled with parallel microtubules and intermediate filaments.
Mitochondria, and occasionally dense-core vesicles and clear vesicles,
were also observed in the processes. In the light microscope, numerous
varicosities were observed along the processes and at terminals. Figure
5C shows that in the electron microscope one such terminal
contains two types of vesicles: dense-core vesicles or granules
(arrows) with an average diameter of 120-160 nm and
smaller, clear vesicles (arrowheads) with an average
diameter of between 60 and 80 nm. Mitochondria and clathrin-coated
vesicles were also observed in the terminals, as well as structures
that resemble actin filament-rich filopodia.
Fig. 5.
Electron micrographs of differentiated CAD cells.
A, Cell body and initial segment of a process in
differentiated CAD cells. The cytoplasm contains ribosomes
(arrowhead), mitochondria (asterisk), rough endoplasmic reticulum (arrow), and microtubules.
B, A typical process is filled with parallel
microtubules (arrow) and intermediate filaments
(arrowhead). C, Dense-core vesicles
(arrow) and clear vesicles (arrowhead) in
terminal. FP, Filopodia; N, nucleus.
Scale bars, 1 µm.
[View Larger Version of this Image (91K GIF file)]
To determine whether synaptic vesicle proteins are present in
terminals, we localized synaptotagmin (p65) by immunofluorescence. Synaptotagmin is an abundant synaptic vesicle protein found exclusively in the nervous system and certain neuronal-like secretory cells (Matthew et al., 1981
; Perin et al., 1991
; Wendland et al., 1991
). Although it is generally considered a synaptic vesicle protein, it is
also present on some dense-core vesicles (Walch-Solimena et al., 1993
;
Egger et al., 1994
). A mAb against synaptotagmin stained both
differentiated and undifferentiated CAD cells (Fig. 6).
Intensive staining was observed in a perinuclear position, which is
likely to mark the Golgi apparatus, and in terminals and varicosities.
This staining pattern is characteristic for synaptotagmin (Tao-Cheng et
al., 1995
). Therefore, ultrastructurally and biochemically
differentiated CAD cells resemble neurons.
Fig. 6.
Immunocytochemical staining of CAD cells with
synaptotagmin mAb. A, CAD cells grown in
serum-containing medium. B, CAD cells grown for 4 d
in PFM.
[View Larger Version of this Image (44K GIF file)]
CAD cells are catecholaminergic neurons
TH protein could be detected by immunohistochemistry in both the
undifferentiated and differentiated CAD cells (Fig. 7).
The staining was heterogeneous from cell to cell and was confined to
the cytoplasm and proximal processes. Differentiated cells had slightly
stronger staining, consistent with data from Western blots showing a
twofold increase in TH protein after differentiation (Lazaroff et al.,
unpublished data).
Fig. 7.
Expression of TH in CAD cells. Immunocytochemistry
with monoclonal TH antibody showing cytoplasmic TH staining in both
growing CAD (A) and differentiated CAD cells
(B).
[View Larger Version of this Image (35K GIF file)]
To determine whether TH is enzymatically active in CAD cells,
catecholamine production was measured by HPLC. Because the parental Cath.a cells have high levels of dopamine and norepinephrine (Table 1; Suri et al., 1993
), we expected similar results in
CAD cells. Contrary to our expectation, we detected no dopamine or
norepinephrine in CAD cell extracts (or in media from CAD-grown cells).
Instead, we observed an accumulation of L-dihydroxyphenylalanine
(L-DOPA), which is the immediate product of TH action on
tyrosine. Undifferentiated CAD cells have 163.17 pmol
L-DOPA/mg protein, whereas differentiated cells have
254.913 pmol/mg protein. The higher level of L-DOPA in
differentiated CAD cells may reflect the higher expression of TH
enzyme. Rat hepatoma cell line, HTC, was used as negative control and
contained no catecholamines. In most TH+ cells, including
Cath.a, DOPA decarboxylase (aromatic amino acid decarboxylase), the
second enzyme in the catecholamine biosynthetic pathway, converts
L-DOPA to dopamine so rapidly that L-DOPA does not accumulate. Hence, it is likely that TH is indeed biologically active in the CAD cells, but the lack of decarboxylase activity prevents conversion of L-DOPA to dopamine.
Table 1.
L-DOPA and dopamine production by
HPLC
| Cell
line |
L-DOPA (pmol/mg) |
DA
(pmol/mg) |
|
| Cath.a |
0 |
1998.59 ± 57.89 (3) |
| CAD |
163.17 ± 9.39 (3) |
0 |
| CADd |
254.913 ± 24.79 (3) |
0 |
| HTC |
0 |
0 |
|
|
Values are expressed as pmol/mg cell protein ± SD
(n). Cells were disrupted, and the filtered cell lysate was
injected onto the HPLC. The minimum detectability is 8.6 pmol for
L-DOPA and 0.263 pmol for dopamine (DA).
|
|
DISCUSSION
We describe here a CNS neuronal cell line that can undergo
reversible morphological differentiation. In serum-containing medium, CAD cells are morphologically undifferentiated and proliferate with a
doubling time of 18-22 hr. After serum withdrawal, they cease
proliferation and differentiate. Insulin and insulin-like growth
factors partially sustain CAD cell proliferation in SFM (our
unpublished data) and, hence, are likely to be among the factors in
serum that maintain cells in the cycle. Therefore, CAD cell
differentiation is likely to be blocked by proliferation rather than by
differentiation inhibitors in serum. Most immortalized cells,
particularly neuronal lines like PC12, ND7 (Howard et al., 1993
;
Lindenboim et al., 1995
), and the parental Cath.a cells from which CAD
cells were derived, die after serum deprivation. Some immortalized
cells and primary neurons can survive for extended periods in SFM
supplemented with transferrin, an iron carrier protein, and a high
concentration of insulin, a growth factor, which may act as a general
survival factor (Bottenstein and Sato, 1979
). With few exceptions,
mammalian cells need trophic factors to survive (Raff, 1992
). It is
surprising that differentiated CAD cells survive without any protein
added to the medium for extended periods, perhaps indefinitely.
However, it is likely that they may make autocrine or paracrine factors
that support their own survival. Alternatively, like neurofibromin
mutant cells (Vogel et al., 1995
), they may have sustained a gain of
function mutation in a signaling pathway, which renders them trophic
factor independent.
It has been thought that the morphological differentiation of
neural progenitors occurs after cells have stopped dividing. In CAD
cells, serum deprivation reduced proliferation greatly, and protein
deprivation stopped the increase in cell number immediately. Our
preliminary data show that overexpression of the tumor suppressor protein p53 is sufficient for morphological differentiation in the
presence of serum (our unpublished data). Because one of the biological
activities of p53 is to arrest cell cycle progression (Oren, 1992
),
cell cycle arrest alone may be sufficient for CAD cell differentiation.
Indeed, our preliminary data are consistent with the notion that CAD
cells differentiate if they are blocked from proliferating by any
number of treatments. When treated with cell cycle blockers (mimosine
and aphidocolin in the presence of serum), morphological changes
consistent with limited differentiation were observed. However, the
processes were shorter and thicker than those in SFM, and significant
toxicity was apparent at all concentrations (our unpublished data).
Hence, differentiation may be the "default" pathway, which is
over-ridden by proliferative signals.
Differentiation is readily reversible. When serum was added back to
cultures in SFM or PFM, more than 95% of the cells retracted their
processes within 12-24 hr and proliferated without a detectable lag
period. Hence, the cells remain sensitive to proliferative signals
unlike most terminally differentiated cells.
In general, it has been difficult to immortalize differentiated neurons
with oncogenes (Noble et al., 1992
). Because retroviruses can only
integrate into a dividing cell, this precludes immortalization of
postmitotic neurons. In addition, oncogenes often prevent
differentiation. For example, activated oncogenes have been shown to
arrest neuronal differentiation of retinoic acid-treated P19 cells
(Boulter and Wagner, 1988
). In PC12 cells, both E1A and
myc oncogenes block nerve growth factor-induced neurite
growth (Maruyama et al., 1987
; Bogenmann et al., 1995
).
Temperature-sensitive oncogenes have been used to generate cell lines
in which the activity of the oncogene can be turned off by culturing
cells at nonpermissive temperature. For example, a temperature
sensitive SV40 Tag was used to generate cell lines in which the
activity of Tag protein can be turned off by growing cells at high
temperature (Chou, 1989
; Eves et al., 1994
; White et al., 1994
).
Although these cell lines differentiate at a nonpermissive temperature,
it is unclear whether they can be maintained for extended periods in
their differentiated state.
Although the initial immortalizing oncogene, SV40 T antigen, was lost
in CAD cells, it is still immortalized. As suggested by Suri et al.
(1993)
, it is likely that the original tumor cells, from which Cath.a
and CAD were derived, required at least two "hits" for full
oncogenic transformation. The primary event was the expression of the
SV40 T antigen transgene, and the second was an unknown mutation that
occurred stochastically over a period of 1 year or more, during which
time tumors arose in vivo (Suri et al., 1993
). Hence, it is
likely that the second immortalizing event sustains proliferation of
the CAD line in the presence of serum. The spontaneous loss of Tag in
CAD cells is fortuitous because this cell line was already committed to
a neuronal phenotype, and differentiation can be easily and reversibly
induced.
CAD cells are quite distinct from parental Cath.a cells, which do not
undergo morphological differentiation. Although both lines express
biologically active tyrosine hydroxylase, CAD cells accumulate
L-DOPA but lack dopamine, suggesting that
L-DOPA decarboxylase activity, which converts DOPA to
dopamine, may be deficient. In contrast, Cath.a cells have high levels
of dopamine and undetectable levels of L-DOPA, which is
converted so rapidly to dopamine it is usually undetectable in most
catecholaminergic cells. The two lines also differ in transcriptional
regulation of tyrosine hydroxylase. The Cath.a cells rely almost
exclusively on the CRE site at
45 for basal enhancer activity. In
contrast, CAD cells rely equally on the CRE and an AP1 site at
205
(Lazaroff et al., unpublished data). This equal and additive ability of
the CRE and AP1 sites to direct transcription is unlike any other
catecholaminergic cell line examined to date.
CAD cells express neuronal markers such as GAP-43, synaptotagmin,
and SNAP-25, which are not found in Cath.a cells. These markers are
present in both proliferating and differentiated cells, although GAP-43
and TH levels are modestly increased after differentiation. At the
ultrastructural level, CAD cell bodies are crowded with ribosomal
profiles, their processes are rich in microtubules and intermediate
filaments, and they have both dense-core and clear vesicles in their
terminals. The dense-core vesicles have an average diameter of 120-160
nm, and the clear vesicles are 60-80 nm. On the basis of light
microscopy, it is likely that synaptotagmin resides in these vesicles.
Although synaptotagmin is generally considered a marker for small (50 nm) synaptic vesicles, it is also found in some dense-core vesicles
(Walch-Solimena et al., 1993
; Egger et al., 1994
). Hence, synaptotagmin
may be in either or both vesicular populations.
In summary, we have established a clonal CNS neuronal cell line
in which morphological differentiation can be initiated and maintained
by removal of serum or protein from the culture media. CAD cells
express biochemical markers found in differentiated neurons and, in
their differentiated state, bear processes that ultrastructurally
resemble neurites, complete with dense-core and clear vesicles. These
properties make this cell line unique and a valuable resource for
studying neuronal differentiation.
FOOTNOTES
Received Sept. 25, 1996; revised Nov. 20, 1996; accepted Nov. 25, 1996.
This work was supported by National Institutes of Health Grants NS30590
(J.K.T.W.) and NS22675 (D.M.C.). We thank Kimberly Stark for assisting
with cloning the cell line and Dr. Sara Jones for performing
L-DOPA and catecholamine assays.
Correspondence should be addressed to Dr. Dona M. Chikaraishi,
Department of Neurobiology, 427G Bryan Research Building, Duke University Medical Center, Durham, NC 27710.
Dr. Qi's present address: Department of Neurobiology, Duke University
Medical Center, Durham, NC 27710.
REFERENCES
-
Amano T,
Richelson E,
Nirenberg M
(1972)
Neurotransmitter synthesis by neuroblastoma clones.
Proc Natl Acad Sci USA
69:258-263 .
[Abstract/Free Full Text]
-
Augusti-Tocco G,
Sato G
(1969)
Establishment of functional clonal lines of neurons from mouse neuroblastoma.
Proc Natl Acad Sci USA
64:311-315 .
[Abstract/Free Full Text]
-
Bogenmann E,
Torres M,
Matsushima H
(1995)
constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation.
Oncogene
10:1915-1925 .
[Web of Science][Medline]
-
Bottenstein JE,
Sato GH
(1979)
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Proc Natl Acad Sci USA
76:514-517 .
[Abstract/Free Full Text]
-
Boulter CA,
Wagner EF
(1988)
The effects of v-src expression on the differentiation of embryonal carcinoma cells.
Oncogene
2:207-214 .
[Web of Science][Medline]
-
Bryan TM,
Reddel RR
(1994)
SV40-induced immortalization of human cells.
Crit Rev Oncog
5:331-357 .
[Web of Science][Medline]
-
Catsicas S
(1993)
Inhibition of axonal growth by SNAP-25 antisence oligonucleotides in vitro and in vivo.
Nature
364:445-448.
[Medline]
-
Catsicas S,
Larhammar D,
Blomqvist A,
Sanna PP,
Milner RJ,
Wilson MC
(1991)
Expression of a conserved cell type-specific protein in nerve terminals coincides with synaptogenesis.
Proc Natl Acad Sci USA
88:785-789 .
[Abstract/Free Full Text]
-
Chou JY
(1989)
Differentiated mammalian cell lines immortalized by temperature-sensitive tumor viruses.
Mol Endocrinol
3:1511-1514 .
[Abstract/Free Full Text]
-
Egger C,
Kirchmair R,
Kapelari S,
Fischer-Colbrie R,
Hogue-Angeletti R,
Winkler H
(1994)
Bovine posterior pituitary: presence of p65 (synaptotagmin), PC1, PC2 and secretoneurin in large dense core vesicles.
Neuroendocrinology
59:169-75 .
[Web of Science][Medline]
-
Eng LF
(1985)
Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.
J Neuroimmunol
8:203-214 .
[Web of Science][Medline]
-
Eves EM,
Kwon J,
Downen M,
Tucker MS,
Wainer BH,
Rosner MR
(1994)
Conditional immortalization of neuronal cells from postmitotic cultures and adult CNS.
Brain Res
656:396-404 .
[Web of Science][Medline]
-
Fanning E
(1992)
Structure and function of simian virus 40 large tumor antigen.
Annu Rev Biochem
61:55-85 .
[Web of Science][Medline]
-
Greene LA,
Tischler AS
(1976)
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
Proc Natl Acad Sci USA
73:2424-2428 .
[Abstract/Free Full Text]
-
Howard MK,
Burke LC,
Maihos C,
Pizzey A,
Gilbert CS,
Lawson D,
Collins MKL,
Thomas NSB,
Latchman DS
(1993)
Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation.
J Neurochem
60:1783-1791 .
[Web of Science][Medline]
-
Jones-Villeneuve EMV,
Mcburney MW,
Rogers KA,
Kalnins VI
(1982)
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells.
J Cell Biol
94:253-262.
[Abstract/Free Full Text]
-
Kalil K,
Skene JHP
(1986)
Elevated synthesis of an axonally transported protein correlates with axon outgrowth in normal and injured pyramidal tracts.
J Neurosci
6:2563-2570 .
[Abstract]
-
Laird PW,
Zijderveld A,
Linders K,
Rudnicki MA,
Jaenisch R,
Berns A
(1991)
Simplified mammalian DNA isolation procedure.
Nucleic Acids Res
19:4293 .
[Free Full Text]
-
Lakin ND,
Morris PJ,
Theil T,
Sato TN,
Moroy T,
Wilson MC,
Latchman DS
(1995)
Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor.
J Biol Chem
270:15858-15863 .
[Abstract/Free Full Text]
-
Lazaroff M,
Dunlap K,
Chikaraishi DM
(1996)
A CNS catecholaminergic cell line expresses voltage-gated currents.
J Membr Biol
151:279-291 .
[Web of Science][Medline]
-
Lindenboim L,
Diamond R,
Rothenberg E,
Stein R
(1995)
Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle.
Cancer Res
55:1242-1247 .
[Abstract/Free Full Text]
-
Maniatis T,
Fritsch EF,
Sambrook J
(1989)
In: Molecular cloning: a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
-
Maruyama K,
Schiavi SC,
Huse W,
Johnson GL,
Ruley HE
(1987)
myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation.
Oncogene
1:361-367 .
[Web of Science][Medline]
-
Matthew WD,
Tsavaler L,
Reichardt LF
(1981)
Identification of a synaptic vesicle-specific membrane protein with a wide distribution in neuronal and neurosecretory tissue.
J Cell Biol
91:257-269 .
[Abstract/Free Full Text]
-
McBurney MW,
Reuhl KR,
Ally AI,
Nasipuri S,
Bell JC,
Craig J
(1988)
Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture.
J Neurosci
8:1063-1073 .
[Abstract]
-
Nelson P,
Ruffner W,
Nirenberg M
(1969)
Neuronal tumor cells with excitable membranes grown in vitro.
Proc Natl Acad Sci USA
64:1004-1009 .
[Abstract/Free Full Text]
-
Noble M,
Groves AK,
Ataliotis P,
Jat PS
(1992)
From chance to choice in the generation of neural cell lines.
Brain Pathol
2:39-46 .
[Web of Science][Medline]
-
Oren M
(1992)
p53: the ultimate tumor suppressor gene?
FASEB J
6:3169-3176 .
[Abstract]
-
Osen-Sand A,
Catsicas M,
Staple JK,
Jones KA,
Ayala G,
Knowles J,
Grenningloh G,
Oyler GA,
Polli JW,
Higgins GA,
Wilson MC,
Billingsley ML
(1992)
Distribution and expression of SNAP-25 immunoreactivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma cells.
Dev Brain Res
65:133-146.
[Medline]
-
Oyler GA,
Polli JW,
Wilson MC,
Billingsley ML
(1991)
Developmental expression of the 25 kDa synaptosomal-associated protein (SNAP-25) in rat brain.
Proc Natl Acad Sci USA
88:5247-5251 .
[Abstract/Free Full Text]
-
Perin MS,
Brose N,
Jahn R,
Sudhof TC
(1991)
Domain structure of synaptotagmin (p65).
J Biol Chem
266:623-629 .
[Abstract/Free Full Text]
-
Pevsner J,
Jsu SH,
Braun JEA,
Calakos N,
Ting AE,
Bennet MK,
Scheller RH
(1994)
Specificity and regulation of a synaptic vesicle docking complex.
Neuron
13:353-361 .
[Web of Science][Medline]
-
Pleasure SJ,
Lee VM-Y
(1993)
NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell.
J Neurosci Res
35:585-602 .
[Web of Science][Medline]
-
Pleasure SJ,
Page C,
Lee VM-Y
(1992)
Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons.
J Neurosci
12:1802-1815 .
[Abstract]
-
Raff MC
(1992)
Social controls on cell survival and cell death.
Nature
356:397-400 .
[Medline]
-
Sabel M,
Bele S,
Gass P,
Sommer C,
Kiessling M
(1995)
Developmental expression of GAP-43 and SNAP-25 in heterotopic rat cortical grafts.
Neurosci Lett
189:151-154 .
[Web of Science][Medline]
-
Schubert D,
Humphreys S,
Baroni C,
Cohn M
(1969)
In vitro differentiation of a mouse neuroblastoma.
Proc Natl Acad Sci USA
64:316-323 .
[Abstract/Free Full Text]
-
Schubert D,
Heinemann S,
Carlisle W,
Tarikas H,
Kimes B,
Patrick J,
Steinbach JH,
Culp W,
Brandt BL
(1974)
Clonal cell lines from the rat central nerous system.
Nature
249:224-227 .
[Medline]
-
Seeds NW,
Gilman AG,
Amano T,
Nirenberg MW
(1970)
Regulation of axon formation by clonal lines of a neural tumor.
Proc Natl Acad Sci USA
66:160-167 .
[Abstract/Free Full Text]
-
Skene JHP,
Jacobson RD,
Snipes GJ,
Mcguire CB,
Norden JJ,
Freeman JA
(1986)
A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes.
Science
233:783-785.
[Abstract/Free Full Text]
-
Strittmatter SM,
Vartanian T,
Fishman MC
(1992)
GAP-43 as a plasticity protein in neuronal form and repair.
J Neurobiol
23:507-520 .
[Web of Science][Medline]
-
Sullivan KF,
Havercroft JC,
Machlin PS,
Cleveland DW
(1986)
Sequence and expression of the chicken
5- and
4-tubulin genes define a pair of divergent
-tubulins with complementary patterns of expression.
Mol Cell Biol
6:4409-4418 .
[Abstract/Free Full Text]
-
Suri C,
Fung BP,
Tischler AS,
Chikaraishi DM
(1993)
Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigenic mice.
J Neurosci
13:1280-1291 .
[Abstract]
-
Tao-Cheng JH,
Dosemeci A,
Bressler JP,
Brightman MW,
Simpson DL
(1995)
Characterization of synaptic vesicles and related neuronal features in nerve growth factor and ras oncogene differentiated PC12 cells.
J Neurosci Res
42:323-334 .
[Web of Science][Medline]
-
Vogel KS,
Brannan CI,
Jenkins NA,
Copeland NG,
Parada LF
(1995)
Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons.
Cell
82:733-742 .
[Web of Science][Medline]
-
Walch-Solimena C,
Takei K,
Marek KL,
Midyett K,
Sudhof TC,
Camilli PD,
Jahn R
(1993)
Synaptotagmin: a membrane constituent of neuropeptide-containing large dense-core vesicles.
J Neurosci
13:3895-3903 .
[Abstract]
-
Wendland B,
Miller KG,
Schilling J,
Scheller RH
(1991)
Differential expression of the p65 gene family.
Neuron
6:993-1007 .
[Web of Science][Medline]
-
White LA,
Eaton MJ,
Castro MC,
Klose KJ,
Globus MY-T,
Shaw G,
Whittemore SR
(1994)
Distinct regulatory pathways contol neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons.
J Neurosci
14:6744-6753 .
[Abstract]
-
Yao M,
Bain G,
Gottlieb DI
(1995)
Neuronal differentiation of P19 embryonal carcinoma cells in defined media.
J Neurosci Res
41:792-804 .
[Web of Science][Medline]
-
Younkin DP,
Tang C-M,
Hardy M,
Reddy UR,
Shi Q-Y,
Pleasure SJ,
Lee VM-Y,
Pleasure D
(1993)
Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line.
Proc Natl Acad Sci USA
90:2174-2178 .
[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
L. E. Eiden
Timing the Phox-Trot: Duration of Phox2a-Dependent Transcription Is Controlled by an Intramolecular Dephosphorylation/Phosphorylation Clock
Mol. Cell. Biol.,
September 15, 2009;
29(18):
4875 - 4877.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dron, F. Dandoy-Dron, M. K. Farooq Salamat, and H. Laude
Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells
J. Gen. Virol.,
August 1, 2009;
90(8):
2050 - 2060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Muresan, N. H. Varvel, B. T. Lamb, and Z. Muresan
The Cleavage Products of Amyloid-{beta} Precursor Protein Are Sorted to Distinct Carrier Vesicles That Are Independently Transported within Neurites
J. Neurosci.,
March 18, 2009;
29(11):
3565 - 3578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Reiterer, S. Maier, H. H. Sitte, A. Kriz, M. A. Ruegg, H.-P. Hauri, M. Freissmuth, and H. Farhan
Sec24- and ARFGAP1-Dependent Trafficking of GABA Transporter-1 Is a Prerequisite for Correct Axonal Targeting
J. Neurosci.,
November 19, 2008;
28(47):
12453 - 12464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-A. Vidi, B. R. Chemel, C.-D. Hu, and V. J. Watts
Ligand-Dependent Oligomerization of Dopamine D2 and Adenosine A2A Receptors in Living Neuronal Cells
Mol. Pharmacol.,
September 1, 2008;
74(3):
544 - 551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. McFarland, T. K. Bardell, M. L. Yates, E. A. Placzek, and E. L. Barker
RNA Interference-Mediated Knockdown of Dynamin 2 Reduces Endocannabinoid Uptake into Neuronal dCAD Cells
Mol. Pharmacol.,
July 1, 2008;
74(1):
101 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Y. Shim, B. A. Samuels, J. Wang, G. Neumayer, C. Belzil, R. Ayala, Y. Shi, Y. Shi, L.-H. Tsai, and M. D. Nguyen
Ndel1 Controls the Dynein-mediated Transport of Vimentin during Neurite Outgrowth
J. Biol. Chem.,
May 2, 2008;
283(18):
12232 - 12240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, J. B. Dictenberg, L. Ku, W. Li, G. J. Bassell, and Y. Feng
Dynamic Association of the Fragile X Mental Retardation Protein as a Messenger Ribonucleoprotein between Microtubules and Polyribosomes
Mol. Biol. Cell,
January 1, 2008;
19(1):
105 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Mahal, C. A. Baker, C. A. Demczyk, E. W. Smith, C. Julius, and C. Weissmann
Prion strain discrimination in cell culture: The cell panel assay
PNAS,
December 26, 2007;
104(52):
20908 - 20913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Bolger, X. Zhao, T. J. Cohen, C.-C. Tsai, and T.-P. Yao
The Neurodegenerative Disease Protein Ataxin-1 Antagonizes the Neuronal Survival Function of Myocyte Enhancer Factor-2
J. Biol. Chem.,
October 5, 2007;
282(40):
29186 - 29192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Muresan and V. Muresan
The Amyloid-beta Precursor Protein Is Phosphorylated via Distinct Pathways during Differentiation, Mitosis, Stress, and Degeneration
Mol. Biol. Cell,
October 1, 2007;
18(10):
3835 - 3844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Free, L. A. Hazelwood, D. M. Cabrera, H. N. Spalding, Y. Namkung, M. L. Rankin, and D. R. Sibley
D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin
J. Biol. Chem.,
July 20, 2007;
282(29):
21285 - 21300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol.,
January 1, 2007;
71(1):
230 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paris, W.-H. Wang, M.-H. Shin, D. S. Franklin, and O. M. Andrisani
Homeodomain Transcription Factor Phox2a, via Cyclic AMP-Mediated Activation, Induces p27Kip1 Transcription, Coordinating Neural Progenitor Cell Cycle Exit and Differentiation
Mol. Cell. Biol.,
December 1, 2006;
26(23):
8826 - 8839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Muresan and V. Muresan
Neuritic Deposits of Amyloid-{beta} Peptide in a Subpopulation of Central Nervous System-Derived Neuronal Cells.
Mol. Cell. Biol.,
July 1, 2006;
26(13):
4982 - 4997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Carraro-Lacroix, M. A. Ramirez, T. M. T. Zorn, N. A. Reboucas, and G. Malnic
Increased NHE1 expression is associated with serum deprivation-induced differentiation in immortalized rat proximal tubule cells
Am J Physiol Renal Physiol,
July 1, 2006;
291(1):
F129 - F139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kock, T. V. Naismith, H. E. Boston, L. J. Ozelius, D. P. Corey, X. O. Breakefield, and P. I. Hanson
Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier
Hum. Mol. Genet.,
April 15, 2006;
15(8):
1355 - 1364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lambrechts, V. Jonckheere, C. Peleman, D. Polet, W. De Vos, J. Vandekerckhove, and C. Ampe
Profilin-I-ligand interactions influence various aspects of neuronal differentiation
J. Cell Sci.,
April 15, 2006;
119(8):
1570 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Benjanirut, M. Paris, W.-H. Wang, S. J. Hong, K. S. Kim, R. L. Hullinger, and O. M. Andrisani
The cAMP Pathway in Combination with BMP2 Regulates Phox2a Transcription via cAMP Response Element Binding Sites
J. Biol. Chem.,
February 3, 2006;
281(5):
2969 - 2981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Sousa, J. S. Berg, B. W. Robertson, R. B. Meeker, and R. E. Cheney
Myo10 in brain: developmental regulation, identification of a headless isoform and dynamics in neurons
J. Cell Sci.,
January 1, 2006;
119(1):
184 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, M. Ji, M. Paris, R. L. Hullinger, and O. M. Andrisani
The cAMP Pathway Regulates Both Transcription and Activity of the Paired Homeobox Transcription Factor Phox2a Required for Development of Neural Crest-derived and Central Nervous System-derived Catecholaminergic Neurons
J. Biol. Chem.,
December 9, 2005;
280(49):
41025 - 41036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Muresan and V. Muresan
Coordinated transport of phosphorylated amyloid-{beta} precursor protein and c-Jun NH2-terminal kinase-interacting protein-1
J. Cell Biol.,
November 21, 2005;
171(4):
615 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Muresan and V. Muresan
c-Jun NH2-Terminal Kinase-Interacting Protein-3 Facilitates Phosphorylation and Controls Localization of Amyloid-{beta} Precursor Protein
J. Neurosci.,
April 13, 2005;
25(15):
3741 - 3751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Perez-Olle, S. T. Jones, and R. K.H. Liem
Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models
Hum. Mol. Genet.,
October 1, 2004;
13(19):
2207 - 2220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Colton, Q. Xu, J. R. Burke, S. Y. Bae, J. K. Wakefield, A. Nair, W. J. Strittmatter, and M. P. Vitek
Disrupted Spermine Homeostasis: A Novel Mechanism in Polyglutamine-Mediated Aggregation and Cell Death
J. Neurosci.,
August 11, 2004;
24(32):
7118 - 7127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kamm, H. Boston, J. Hewett, J. Wilbur, D. P. Corey, P. I. Hanson, V. Ramesh, and X. O. Breakefield
The Early Onset Dystonia Protein TorsinA Interacts with Kinesin Light Chain 1
J. Biol. Chem.,
May 7, 2004;
279(19):
19882 - 19892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Muresan and V. Muresan
A phosphorylated, carboxy-terminal fragment of {beta}-amyloid precursor protein localizes to the splicing factor compartment
Hum. Mol. Genet.,
March 1, 2004;
13(5):
475 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Vortherms and V. J. Watts
Sensitization of Neuronal A2A Adenosine Receptors after Persistent D2 Dopamine Receptor Activation
J. Pharmacol. Exp. Ther.,
January 1, 2004;
308(1):
221 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Goriounov, C. L. Leung, and R. K. H. Liem
Protein products of human Gas2-related genes on chromosomes 17 and 22 (hGAR17 and hGAR22) associate with both microfilaments and microtubules
J. Cell Sci.,
March 15, 2003;
116(6):
1045 - 1058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Sung, S. Apparsundaram, A. Galli, K. M. Kahlig, V. Savchenko, S. Schroeter, M. W. Quick, and R. D. Blakely
A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity
J. Neurosci.,
March 1, 2003;
23(5):
1697 - 1709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhu, I. Watanabe, B. Gomez, and W. B. Thornhill
Determinants Involved in Kv1 Potassium Channel Folding in the Endoplasmic Reticulum, Glycosylation in the Golgi, and Cell Surface Expression
J. Biol. Chem.,
October 12, 2001;
276(42):
39419 - 39427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Boukhelifa, M. M. Parast, J. G. Valtschanoff, A. S. LaMantia, R. B. Meeker, and C. A. Otey
A Role for the Cytoskeleton-associated Protein Palladin in Neurite Outgrowth
Mol. Biol. Cell,
September 1, 2001;
12(9):
2721 - 2729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Verhey, D. Meyer, R. Deehan, J. Blenis, B. J. Schnapp, T. A. Rapoport, and B. Margolis
Cargo of Kinesin Identified as Jip Scaffolding Proteins and Associated Signaling Molecules
J. Cell Biol.,
March 5, 2001;
152(5):
959 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang and G. S. Oxford
Voltage-Dependent Ion Channels in CAD Cells: A Catecholaminergic Neuronal Line That Exhibits Inducible Differentiation
J Neurophysiol,
December 1, 2000;
84(6):
2888 - 2895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. ERICKSON and H. VAROQUI
Molecular analysis of vesicular amine transporter function and targeting to secretory organelles
FASEB J,
December 1, 2000;
14(15):
2450 - 2458.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Hewett, C. Gonzalez-Agosti, D. Slater, P. Ziefer, S. Li, D. Bergeron, D. J. Jacoby, L. J. Ozelius, V. Ramesh, and X. O. Breakefield
Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells
Hum. Mol. Genet.,
May 22, 2000;
9(9):
1403 - 1413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. M. Weber and J. H. P. Skene
The Activity of a Highly Promiscuous AP-1 Element Can Be Confined to Neurons by a Tissue-Selective Repressive Element
J. Neurosci.,
July 15, 1998;
18(14):
5264 - 5274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. M. Weber and J. H. P. Skene
Identification of a Novel Repressive Element That Contributes to Neuron-Specific Gene Expression
J. Neurosci.,
October 15, 1997;
17(20):
7583 - 7593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Patankar, M. Lazaroff, S. O. Yoon, and D. M. Chikaraishi
A Novel Basal Promoter Element Is Required for Expression of the Rat Tyrosine Hydroxylase Gene
J. Neurosci.,
June 1, 1997;
17(11):
4076 - 4086.
[Abstract]
[Full Text]
[PDF]
|
 |
|